SFX by Ex Libris Inc.

Title:	Sequential regulation of DOCK2 dynamics by two phospholipids during neutrophil chemotaxis
Source:	Science [0036-8075] Nishikimi, A yr:2009

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Wang, F. "Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils." Nature cell biology 4.7 (2002): 513-8.
description	2.	Hahn, Klaus M M. "Activation of endogenous Cdc42 visualized in living cells." Science 305.5690 (2004): 1615-9.
description	3.	Huang, T. "Cofilin phosphatases and regulation of actin dynamics." Current opinion in cell biology 18.1 (2006): 26-31.
description	4.	Lakkaraju, A. "SRP keeps polypeptides translocation-competent by slowing translation to match limiting ER-targeting sites." Cell 133.3 (2008): 440-451.
description	5.	Sliva, D. "Signaling pathways responsible for cancer cell invasion as targets for cancer therapy." Current cancer drug targets 4.4 (2004): 327-336.
description	6.	Pertz, O. "Spatiotemporal dynamics of RhoA activity in migrating cells." Nature 440.7087 (2006): 1069-72.
description	7.	Rafelski, Julie A M. "Crawling toward a unified model of cell motility: Spatial and temporal regulation of actin dynamics." Annual review of biochemistry 73.1 (2004): 209-239.
description	8.	Goforth, RL. "An evolutionary replacement for the ribosome in post-translational signal recognition particle (SRP)-based protein targeting." The FASEB journal 2005.
description	9.	Kondrashov, N. "Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning." Cell 145.3 (2011): 383-97.
description	10.	Lahn, M. "Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer." Seminars in oncology 30.2 Suppl 3 (2003): 30-3.
description	11.	Simon, R. "In silico simulation of inhibitor drug effects on nuclear factor-kappa B pathway dynamics." Molecular pharmacology 66.1 (2004): 70-75.
description	12.	Hamachi, I. "Ligand-directed tosyl chemistry for protein labeling in vivo." Nature Chemical Biology 5.5 (2009): 341-343.
description	13.	Sadeh, R. "The N-terminal domain of MyoD is necessary and sufficient for its nuclear localization-dependent degradation by the ubiquitin system." Proceedings of the National Academy of Sciences of the United States of America 105.41 (2008): 15690-15695.
description	14.	Rahdar, M. "A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN." Proceedings of the National Academy of Sciences of the United States of America 106.2 (2009): 480-485.
description	15.	Jorgensen, M. "Grp78 is involved in retention of mutant low density lipoprotein receptor protein in the endoplasmic reticulum." The Journal of biological chemistry 275.43 (2000): 33861-33868.
description	16.	Lehman, N. "Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2." Blood 108.10 (2006): 3564-3572.
description	17.	Laffargue, M. "Phosphoinositide 3-kinase signalling--which way to target?" Trends in Pharmacological Sciences 24.7 (2003): 366-76.
description	18.	Bokoch, Gary M., Gary M. "Regulation of innate immunity by Rho GTPases." Trends in cell biology 15.3 (2005): 163-171.
description	19.	Lizana, L. "Controlling the rates of biochemical reactions and signaling networks by shape and volume changes." Proceedings of the National Academy of Sciences of the United States of America 105.11 (2008): 4099-104.
description	20.	Shaulian, E. "AP-1 as a regulator of cell life and death." Nature cell biology 4.5 (2002): 131-6.